Clinical trial
A Randomized, Open Label Controlled Trial of OASIS® Ultra Tri-Layer Matrix Compared to Standard Care in the Healing of Diabetic Foot Ulcers
NCT01835379 is registered in ClinicalTrials.gov with Healthpoint as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open Label Controlled Trial of OASIS® Ultra Tri-Layer Matrix Compared to Standard Care in the Healing of Diabetic Foot Ulcers
- Lead sponsor
- Healthpoint
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2013
- Completion date
- September 30, 2014
- Enrollment
- 82 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer